The independent source for health policy research, polling, and news.
61-80 of 1,311 results
Doctors say acetaminophen, the main ingredient in Tylenol, is safe to take during pregnancy. Other over-the-counter pain relievers such as aspirin and ibuprofen aren’t recommended because they can harm fetal development. Untreated fever in pregnancy can pose maternal and fetal health risks.
The White House’s autism announcement exaggerates links to Tylenol, misleads on vaccines, and sets back the field by ignoring decades of research, scientists say.
Some researchers suspect that rising prescription drug use may explain a disturbing trend.
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn’t make sense, former officials said.
With less than three weeks before the deadline to pass legislation to keep the federal government running, lawmakers are still far apart on a strategy. Democrats hope Republicans will agree to extend expanded tax credits for the Affordable Care Act as part of a compromise, but so far Republicans are not negotiating. Meanwhile, HHS Secretary Robert F. Kennedy Jr. released his long-awaited “Make America Healthy Again” report, with few specific action items. Anna Edney of Bloomberg News, Sandhya Raman of CQ Roll Call, and Lauren Weber of The Washington Post join KFF Health News’ Julie Rovner to discuss these stories and more.
A combative Robert F. Kennedy Jr, the U.S. secretary of health and human services, appeared before a Senate committee Thursday, defending his firing of the newly confirmed director of the Centers for Disease Control and Prevention as well as other changes that could limit the availability of vaccines. Meanwhile, Congress has only a few weeks to complete work on annual spending bills to avoid a possible government shutdown and to ward off potentially large increases in premiums for Affordable Care Act health plans. Jessie Hellmann of CQ Roll Call, Sarah Karlin-Smith of Pink Sheet, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Tony Leys, who discusses his “Bill of the Month” report about a woman’s unfortunate interaction with a bat — and her even more unfortunate interaction with the bill for her rabies prevention treatment.
Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But a growing number of researchers, payers, and providers are challenging that consensus and exploring whether — and how — to taper patients off expensive GLP-1 drugs.
Four senior officials with the Centers for Disease Control and Prevention announced their resignations in recent days, citing what they described as growing political interference in the agency's scientific work, particularly regarding vaccines.
Xlear, a maker of xylitol gum, has sued the Federal Trade Commission, saying the onus should be on government to prove that ingredients don’t live up to advertised claims. RFK Jr.’s “medical freedom” allies have rallied to the cause.
Insurers will take drug costs, frequency of use, and other factors into account as they set premium amounts for the 2026 plan year.
The Health and Human Services secretary is winding down nearly $500 million in mRNA research funding, citing false claims that the technology is ineffective against respiratory illnesses — and notching a victory for critics of the covid vaccines. And President Donald Trump is demanding drugmakers drop their prices, quickly, but it’s unclear how he could make them comply. Lauren Weber of The Washington Post, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Emmarie Huetteman to discuss these stories and more.
In their zeal to “Make America Healthy Again,” top Trump administration officials depict patients and the doctors who treat them as partly responsible for whatever ails them.
Medicaid may have monopolized Washington’s attention lately, but big changes are coming to the Affordable Care Act as well. Meanwhile, Americans are learning more about what’s in Trump’s big budget law, and polls suggest many don’t like what they see. Julie Appleby of KFF Health News, Jessie Hellmann of CQ Roll Call, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews historian Jonathan Oberlander to mark Medicare’s 60th anniversary.
The Senate narrowly approved the Trump administration’s request to claw back about $9 billion for foreign aid and public broadcasting but refused to cut funding for the international AIDS/HIV program PEPFAR. Meanwhile, a federal appeals court ruled that West Virginia can ban the abortion pill mifepristone, which could allow states to block other FDA-approved drugs. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more.
Significant numbers of older people have the condition. Many find relief with an effective treatment that is being more widely prescribed.
In this second part of a two-part series on dealing with the high price of prescription drugs, experts share their insider tips.
KFF Health News journalists made the rounds on national and regional media this week to discuss topical stories. Here’s a collection of their appearances.
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
The Supreme Court this week said Tennessee may continue to enforce its law banning most types of gender-affirming care for minors. The ruling is likely to greenlight similar laws in two dozen states. And the Senate is preparing to vote on a budget reconciliation bill that includes even deeper Medicaid cuts than the House version. Victoria Knight of Axios, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more.
In Part 1 of a two-part series on dealing with the high price of prescription drugs, a father explains the strategies he used to get his daughter the medicine she needs to treat her epilepsy.
© 2026 KFF